Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)

May 21, 2026 6:38 AM
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $200.00 price target on Belite Bio, Inc, ADR (NASDAQ: BLTE).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments